Find grants for Education Services

Total Dollars Available
$ 100 Trillion

Add Your Heading Text Here

Showing 25 of 127 grants in "Education"

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-145

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Deadline: September 7, 2027


Opportunity Number: PAR-24-325

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-24-311

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.395, 93.396

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-175

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.395, 93.394

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-079

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.395, 93.394

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Deadline: October 25, 2027


Opportunity Number: PAR-25-103

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: October 25, 2027

Status: Posted

CFDA Numbers: 93.399

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Deadline: October 25, 2027


Opportunity Number: PAR-25-104

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: October 25, 2027

Status: Posted

CFDA Numbers: 93.399

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-143

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.273, 93.989, 93.307, 93.172, 93.866, 93.399, 93.846, 93.361, 93.173, 93.121, 93.113, 93.855, 93.865, 93.213, 93.853, 93.310

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Deadline: June 2, 2027


Opportunity Number: PAR-25-210

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: June 2, 2027

Status: Posted

CFDA Numbers: 93.866, 93.313, 93.393, 93.213, 93.121

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Deadline: June 2, 2027


Opportunity Number: PAR-25-211

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: June 2, 2027

Status: Posted

CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-233

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.121, 93.279, 93.310, 93.113, 93.853, 93.172, 93.989, 93.273, 93.865, 93.866

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Deadline: January 27, 2027


Opportunity Number: PAR-24-268

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 27, 2027

Status: Posted

CFDA Numbers: 93.121, 93.242, 93.866, 93.273, 93.859, 93.853, 93.213, 93.867, 93.279, 93.310, 93.846

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-144

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.273, 93.866, 93.847, 93.307, 93.172, 93.846, 93.399, 93.853, 93.837, 93.361, 93.867, 93.855, 93.213, 93.121, 93.865, 93.113, 93.839, 93.840, 93.233, 93.838, 93.310

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Deadline: April 15, 2027


Opportunity Number: PAR-25-131

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: April 15, 2027

Status: Posted

CFDA Numbers: 93.879

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Deadline: December 3, 2026


Opportunity Number: PAR-24-295

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: December 3, 2026

Status: Posted

CFDA Numbers: 93.173, 93.313, 93.853, 93.172, 93.838, 93.866, 93.839, 93.279, 93.837, 93.398, 93.113, 93.233, 93.840, 93.242, 93.989

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Deadline: December 3, 2026


Opportunity Number: PAR-24-296

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: December 3, 2026

Status: Posted

CFDA Numbers: 93.989, 93.172, 93.867, 93.233, 93.866, 93.313, 93.839, 93.121, 93.838, 93.840, 93.853, 93.113, 93.398, 93.279, 93.242, 93.173, 93.837

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-098

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.307, 93.121, 93.313

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2027


Opportunity Number: PAR-24-293

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: August 18, 2027

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PA-25-080

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.394, 93.867, 93.273, 93.859, 93.121, 93.310, 93.350, 93.853, 93.855, 93.233, 93.395, 93.837, 93.279, 93.393, 93.213, 93.172, 93.113, 93.846, 93.866, 93.838, 93.879, 93.839, 93.286, 93.399, 93.361, 93.242, 93.396, 93.840

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Deadline: June 15, 2027


Opportunity Number: RFA-MH-26-120

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: June 15, 2027

Status: Posted

CFDA Numbers: 93.213, 93.867, 93.853, 93.286, 93.865, 93.242, 93.279, 93.273, 93.866, 93.173

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Deadline: January 15, 2027


Opportunity Number: RFA-NS-25-023

Agency: National Institutes of Health

Open Date: September 18, 2024

Close Date: January 15, 2027

Status: Posted

CFDA Numbers: 93.846, 93.121, 93.213, 93.273, 93.847, 93.865, 93.393, 93.866, 93.853, 93.867

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-043

Agency: National Institutes of Health

Open Date: September 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393, 93.396

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-044

Agency: National Institutes of Health

Open Date: September 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.396, 93.399

Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-24-273

Agency: National Institutes of Health

Open Date: August 27, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.307, 93.361, 93.866, 93.393

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Deadline: February 11, 2027


Opportunity Number: PAR-24-269

Agency: National Institutes of Health

Open Date: August 13, 2024

Close Date: February 11, 2027

Status: Posted

CFDA Numbers: 93.279

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.